This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Christina Ödman: Innovator in Pharmaceutical Manufacturing
Introduction
Christina Ödman is a notable inventor based in Mariefred, Sweden. She has made significant contributions to the field of pharmaceutical manufacturing, particularly through her innovative processes. Her work has been recognized for its potential impact on the production of important medications.
Latest Patents
Christina holds a patent for a manufacturing process that details a method for the manufacture of clevidipine. This process involves the reaction of an inorganic salt of 4-(2′,3′-dichlorophenyl)-1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-3-pyridine-carboxylate and chloro methyl butyrate. This patent showcases her expertise in chemical processes and her commitment to advancing pharmaceutical technology.
Career Highlights
Christina is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca allows her to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative drug manufacturing techniques.
Collaborations
Throughout her career, Christina has collaborated with talented professionals in her field. Notable coworkers include Carina Svensson and Karin Thörnblom, who have contributed to her projects and shared insights that enhance the quality of their work.
Conclusion
Christina Ödman is a pioneering inventor whose work in pharmaceutical manufacturing is making a difference in the industry. Her patent for the manufacturing process of clevidipine exemplifies her innovative spirit and dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
